Searchable abstracts of presentations at key conferences in endocrinology

ea0036P74 | (1) | BSPED2014

Impaired insulin and IGF2 signalling in the primordial growth disorder 3-M syndrome

Kallampallil Jins , Acimovic Ksenija , Hanson Daniel , Whatmore Andrew , Clayton Peter

Introduction: 3-M syndrome is associated with mutations in CUL7, OBSL1 and CCDC8 with the three proteins interacting within a novel growth pathway. The impact of this pathway on cellular growth has not been fully defined. We have shown that i) GH and IGF1 signalling are altered; ii) IGF2 expression is reduced and iii) expression of insulin receptor isoforms are altered in 3-M fibroblasts.Aim: To characterise the activa...

ea0012p78 | Pituitary | SFE2006

Upregulation of Id1 and Id3 in response to BMP2 stimulation in LβT2 cells

Hanson PL , Sidhu KK , Schwarz N , Milligan T , Burrin JM

The pathogenesis of gonadotrophin secreting pituitary tumours (gonadotrophinomas) remains poorly understood. Bone morphogenetic proteins (BMPs) are important for the control of cell proliferation and differentiation and BMP2 is essential for commitment of undifferentiated pituitary cells to the gonadotroph cell lineage. In addition, BMPs have been implicated in tumourigenesis in a variety of tissues, associated with up-regulated expression of Id (Inhibitors of differentiation)...

ea0081p334 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Health outcomes following engagement with a digital health tool GroHealth app amongst people with type 2 diabetes

Abdelhameed Farah , Pearson Elle , Hanson Petra , Barber Thomas , Panesar Arjun , Summers Charlotte , de la Fosse Michaela

Introduction: Diabetes is a chronic condition causing morbidity and mortality globally, with a growing economic burden on healthcare systems. In the UK, 1 in 14 people have diabetes, with type 2 accounting for 90% of cases (1). Complications from poorly controlled diabetes are associated with increased socioeconomic costs and a reduced quality of life. Research has shown education and self-management are crucial in helping diabetic patients achieve metabolic control (1). Smart...

ea0066oc3.1 | Oral Communications 3 | BSPED2019

Using quality improvement methods to enhance HbA1c outcomes for newly diagnosed children and young people with diabetes

Hanson Frances , Stephenson Tracey , Exall Jane , Bacon Carol , Gelder Carole , Buggins Sarah , Rodgers Callum

Introduction: There is increasing emphasis on stringent glycaemic control (HbA1c <48 mmol/mol) within the first year of diagnosis for all types of diabetes, to preserve metabolic memory and reduce future risk of sub-optimal diabetes outcomes. Retrospective data collected on two previous annual cohorts of children and young people (CYP) with diabetes revealed only 9% achieved the HbA1c < 48 mmol/mol target at 12 months post diagnosis despite initial HbA1c improvement un...

ea0049ep928 | Pituitary - Basic | ECE2017

GPR101 orphan receptor: a novel cause of growth hormone deregulation

Abboud Dayana , Daly Adrian , Dupuis Nadine , Laschet Celine , Pirotte Bernard , Beckers Albert , Hanson Julien

GPR101 is an orphan G-protein coupled receptor with unknown ligand. In 2014, an international study clearly pointed to a strong association between this receptor and the X-linked acrogigantism (X-LAG) syndrome, which begins in childhood and causes the “tallest giants”. The children (carriers of the GPR101 duplication on the X chromosome) grow abnormally even before they are one year old, secrete phenomenal quantities of growth hormone, and develop pituitary adenomas ...

ea0028p77 | Clinical practice/governance and case reports | SFEBES2012

Haemofiltration as a treatment for severe, resistant hypercalcaemia

Pittaway James , Raja Omair , O'Toole Sam , Gunganah Kirun , Srirangalingam Umasuthan , Hanson Philippa , Drake William

Introduction: We describe two patients admitted to our institution with severe hypercalcaemia, resistant to conventional treatment, requiring haemofiltration. Patient 1 was admitted to hospital with profound hypercalcaemia (5.8 mmol/L) secondary to primary hyperparathyroidism (PTH >263 Pmol/L). The hypercalcaemia had been discovered on a surgical admission 3 months previously and was being managed with 0.9% normal saline and pamidronate infusions at an outside hospital. On...

ea0024p16 | (1) | BSPED2010

IGF-2 deficiency in the growth disorder 3-M syndrome

Murray P , Hanson D , Whatmore A , Black G C M , Clayton P E

Introduction: 3-M syndrome is an autosomal recessive disorder characterised by pre- and postnatal growth restriction, characteristic facial dysmorphism, normal intelligence and radiological features (slender long bones and tall vertebral bodies). It is known to be caused by mutations in the genes encoding Cullin 7 (a component of the ubiquitination system) and Obscurin like-1 (a cytoskeletal protein). The mechanisms through which mutations in these genes impair growth are uncl...

ea0021pl8 | Clinical Endocrinology Trust Lecture | SFEBES2009

Ubiquitination: the ‘Kiss of Death' for human growth

Clayton Peter E , Hanson Dan , Murray Philip , Sud Amit , Black Graeme

Ubiquitination (Ub) is the process that controls the level and activity of cellular proteins. Mono-ubiquitination of a protein alters its function, while poly-ubiquitination targets a protein for degradation (as the ‘kiss of death’). Alterations in the Ub system are associated with a wide range of disease, e.g. cancer, neurological diseases and viral infection.Disorders of growth where the phenotype is primarily short stature are usually caused...

ea0017p3 | (1) | BSPED2008

Novel Cullin 7 mutations in 3-M syndrome and exclusion of Fbxw8 mutations in non-CUL7 3M syndrome

Sud A , Murray P , Hanson D , Khan W , Chandler K , Whatmore A , Black G , Clayton P

3-M syndrome is an autosomal recessive disorder characterised by severe pre- and post-natal growth failure, a characteristic facial appearance (triangular shaped face, fleshy tipped nose) and radiological features (slender long bones and tall vertebrae). 3-M syndrome is known to be caused by mutations throughout the Cullin 7 gene, identified in a range of ethnic groups including Brazilian, European, Moroccan, Yakutskian and Indian.We have now identified ...

ea0015p263 | Pituitary | SFEBES2008

Endoscopic transphenoidal pituitary surgery: results in 21 consecutive patients with Cushing’s disease

Hanson Philippa , Akker Scott , Monson John , Alusi Gus , Sabin Ian , Drake Will

Introduction: We present the outcome for the first 21 patients undergoing neuronavigation–guided, endoscopic transphenoidal surgery for pituitary dependent Cushing’s disease in our centre since August 2001. All operations were consecutive, and undertaken by the same neurosurgeon and endoscopic nasal surgeon.Methods: Records are available for 20 cases. Pre and post operative management of cases was led by the endocrine team with standard assessm...